Publications by authors named "Martin Koser"

Claim this Profile
F
Frailty as Predictor for Early Functional Outcomes After Radical Prostatectomy.
Mladen Stankovic, Christian Weber, Martin Koser, Norbert Weidner

J Frailty Sarcopenia Falls· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.
Chengjung Lai, Natalie Pursell, Jessica Gierut, Utsav Saxena, Wei Zhou, Martin Koser

Mol Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.
Shanthi Ganesh, Xue Shui, Kevin P Craig, Martin L Koser, Girish R Chopda

Mol Cancer Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent effects of siRNA-mediated inhibition of SCAP on PCSK9, LDLR, and plasma lipids in mouse and rhesus monkey.
Kristian K Jensen, Marija Tadin-Strapps, Sheng-Ping Wang, James Hubert, Yanqing Kan, Martin Koser

J Lipid Res· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.
Shanthi Ganesh, Martin L Koser, Wendy A Cyr, Girish R Chopda, Junyan Tao

Mol Cancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
Chaitali Dutta, Nicole Avitahl-Curtis, Natalie Pursell, Marita Larsson Cohen, Benjamin Holmes, Martin Koser

Mol Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of EGLN1 siRNA yields increased erythropoiesis in nonhuman primates.
Marc T Abrams, Martin Koser, Julja Burchard, Walter Strapps, Huseyin Mehmet

Nucleic Acid Ther· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interspecies protein substitution to investigate the role of the lyssavirus glycoprotein.
Denise A Marston, Lorraine M McElhinney, Ashley C Banyard, Daniel L Horton, Alejandro Núñez, Martin L Koser

J Gen Virol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of biological matrix and sample preparation on qPCR quantitation of siRNA drugs in animal tissues.
Jessica Seitzer, Hangchun Zhang, Martin Koser, Yi Pei, Marc Abrams

J Pharmacol Toxicol Methods· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative evaluation of siRNA delivery in vivo.
Yi Pei, Paula J Hancock, Hangchun Zhang, René Bartz, Craig Cherrin, Martin L Koser

RNA· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment.
Marc T Abrams, Martin L Koser, Jessica Seitzer, Stephanie C Williams, Martha A DiPietro

Mol Ther· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.
Philip M McKenna, Martin L Koser, Kevin R Carlson, David C Montefiori, Norman L Letvin

J Infect Dis· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabies virus glycoprotein as a carrier for anthrax protective antigen.
Mary Ellen Smith, Martin Koser, Sa Xiao, Catherine Siler, James P McGettigan

Virology· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced humoral HIV-1-specific immune responses generated from recombinant rhabdoviral-based vaccine vectors co-expressing HIV-1 proteins and IL-2.
James P McGettigan, Martin L Koser, Philip M McKenna, Mary Ellen Smith, Julie M Marvin

Virology· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strong cellular and humoral anti-HIV Env immune responses induced by a heterologous rhabdoviral prime-boost approach.
Gene S Tan, Philip M McKenna, Martin L Koser, Robert McLinden, Jerome H Kim

Virology· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rabies virus nucleoprotein as a carrier for foreign antigens.
Martin L Koser, James P McGettigan, Gene S Tan, Mary Ellen Smith, Hilary Koprowski

Proc Natl Acad Sci U S A· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
James P McGettigan, Kristin Naper, Jan Orenstein, Martin Koser, Philip M McKenna

J Virol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis